Journal of Medicinal Chemistry p. 981 - 988 (1992)
Update date:2022-08-04
Topics:
Gubin, Jean
Lucchetti, Jean
Mahaux, Jean
Nisato, Dino
Rosseels, Gilbert
et al.
The synthesis and initial biological evaluation of a series of 1-sulfonylindolizines is described.These compounds have been shown to be representatives of a novel class of potent, slow-channel calcium antagonists.All compounds were found to be at least as active as the reference calcium antagonists verapamil and cis-(+)-diltiazem.Structure-activity relationship studies have shown that all compounds possessing an aralkyl group in the amine moiety and an isopropyl or cyclopropyl group at the 2 position of the indolizine are among the most potent calcium antagonists know n outside the 1,4-dihydropyridine series.The IC50 value for the inhibition of <3H>nitrendipine binding vary between o.19 and 4.5 nM whereas the IC50 value for nifedipine is 2.5 nM.One of the compounds in this group (9ab) has now been selected for clinical development.
View MoreShanghai Bocimed Pharmaceutical Co., Ltd.
website:http://www.bocimed.com
Contact:+86-21-68861632
Address:Building 1, Lane 647, Songtao Road, Zhangjiang High-Tech Park, Shanghai
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Frapp's Chemical (NFTZ) Co.,Ltd
Contact:+86-576-86137892
Address:General Chamber of Commercial Building, 159 Wanchang Middle Road, Wenling, Zhejiang, China
Changzhou BaoKang Pharmaceutical & Chemical Co., Ltd
Contact:(86) 519-88782201 88784080 88785278
Address:Henglin town, changzhou,Jiangsu
HAINAN JINYING IMPORT AND EXPORT CO. LTD
Contact:+86-898-32875423
Address:A SECTION 19TH FL, TIMES SQUARE, NO.2 GUO MAO AVENUE HAIKOU, HAINAN, P. R. OF CHINA
Doi:10.1016/j.tet.2011.08.042
(2011)Doi:10.1021/jo01283a015
(1967)Doi:10.14233/ajchem.2017.20227
(2017)Doi:10.1021/ac60326a041
(1973)Doi:10.1002/cctc.201900358
(2019)Doi:10.1002/ejoc.201500031
(2015)